Stay updated on Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.

Latest updates to the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page
- Check4 days agoChange DetectedThe page’s revision/version indicator at the bottom was updated from v3.5.2 to v3.5.3, reflecting a website software update without changing the underlying study details.SummaryDifference0.1%

- Check11 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.4.2 has been added. The previous notices, including the funding-lapse notice and Revision: v3.4.1, have been removed.SummaryDifference0.5%

- Check83 days agoChange DetectedA government funding lapse notice is now displayed and the site version has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.